Biotech Law Weekly
Welcome to NewsRx!
Learn more about a six-week, no-risk free trial of Biotech Law Weekly
We're a pay-per-view site for premium content. If you'd like to purchase this article, it's only $3.00.
AdvanDx
New rapid species identification test helps physicians identify infection sooner
August 18th, 2006
According to a recently published article in the Journal of Antimicrobial Chemotherapy, AdvanDx's PNA Fish tests provide physicians at the University of Maryland Medical Center (UMMC) with rapid species information the same day a blood culture turns positive, allowing physicians to determine which patients have a true and serious infection. Rapid species identification helps the hospital prevent unnecessary antibiotic use, especially with vancomycin, and reduce the average patient length of stay. A team led by Dr. Graeme Forrest M.D., infectious diseases physician and director of antibiotic utilization at UMMC, describes saving $4,000 per...
Source: Biotech Law Weekly (2006-08-18)
|
